Do you want to read an article? Please log in or register.
Single-agent MOR208 salvage and maintenance therapy in a patient with refractory/relapsing diffuse large B-cell lymphoma: a case report.
Lymphoma
Related content
Lymphoma
Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma
N Engl J Med.
Abramson JS, McGree B, Noyes S, Plummer, S, Wong C, Chen Y, Palmer E, Albertson T, Ferry JA, Arrillaga-Romany IC
doi: 10.1056/NEJMc1704610.
Lymphoma
CD19-Directed CAR T Cells Treatment in a Patient With Refractory DLBCL and CNS Involvement
healthbook TIMS Oncology Hematology
Ring A, Müller A
doi: 10.36000/hbT.OH.2019.01.005
Lymphoma
Primary Cutaneous Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma
Am J Dermatopathol.
Kempf W, Torricelli R, Zettl A, Zimmermann AK, Berisha A, Ghielmini M
doi: 10.1097/DAD.
Lymphoma
Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy
★ 1
Recommended by
Prof. Dr Christoph Renner, Faculty Member
Blood Rev.
Bachanova V, Perales MA, Abramson JS
doi: 10.1016/j.blre.2019.100640.
Lymphoma
Cerebellar large B-cell lymphoma: a case report
doi: 10.1186/s13256-018-1880-z.
Lymphoma
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
Lancet Oncol.
Chiappella A, Martelli M, Angelucci E, Brusamolino E, Evangelista A, Carella AM, Stelitano C, Rossi G, Balzarotti M, Merli F, Gaidano G, Pavone V, Rigacci L, Zaja F, D'Arco A, Cascavilla N, Russo E, Castellino A, Gotti M, Congiu AG, Cabras MG, Tucci A, Agostinelli C, Ciccone G, Pileri SA, Vitolo U
doi: 10.1016/S1470-
Lymphoma
Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin
healthbook Times Oncology Hematology
Schmidt A
doi: 10.36000/hbT.OH.2020.06.025
Lymphoma
A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development
BMC Nephrol.
Khandelwal A, Trinkaus MA, Ghaffar H, Jothy S, Goldstein MB
doi: 10.1186/s12882-016-0349-9.
Lymphoma
Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment
Leuk Lymphoma.
Papin A, Le Gouill S, Chiron D
doi: 10.1080/